The mission of AutoMedx is to improve the survival rate of individuals requiring respiratory support by providing unparalleled access to mechanical ventilation during the first critical minutes of distress. AutoMedx’s strategy is to develop a portfolio of differentiated early resuscitation products geared at raising the standard of care in the pre-hospital environment. The initial focus is on replacing dangerous bag-valve devices in the EMS and military markets with a safe and easy to use simplified automated ventilator (SAVe). Utilizing a bag-valve device to ventilate has been the standard of care in the pre-hospital environment for the last 50 years. However, because a bag-valve mask requires the operator to constantly squeeze the bag, it does not guarantee consistent air delivery. Bagging requires significant concentration and skill in stressful situations. With every squeeze of the bag, the rescuer is selecting the respiratory rate and tidal volume. This can be extremely difficult to do properly even for the most highly trained professionals. Keeping artificial ventilation rates low is difficult because the high-adrenaline state of the rescuer alters time perception, and the rapidly refilling bag-ventilation systems set up a reflex in which rescuers are inclined to deliver breaths as soon as the bag inflates. As a result, bag-valve resuscitation has been linked to high incidence of hyperventilation, which adversely affects patients in cardiac arrest, patients with traumatic brain injury, and patients in shock. Bagging has also been linked to gastric insufflation, regurgitation and subsequent aspiration. AutoMedx was founded in 2004 by retired military doctor Col William Wiesmann, James Evans, Alex Pranger, Adrian Urias and Earl Smith. In his last role in the Army Dr. Wiesmann served as Director of Combat Casualty Care. In that capacity he was responsible for insuring the soldiers had the products and therapies needed to provide medical care on the battlefield. He liaised with medics, physicians and the private sector to develop new products that improved triage capabilities and raised the standard of care. AutoMedx’s first product was built with support from the Air Force Force Protection BattleLab and the Defense Advanced Research Project Agency (DARPA). The SAVe received FDA 510(k) clearance in September of 2007 and Rotary Airworthiness Certification in August 2008. More than 4,500 SAVe ventilators have been sold. Sales, marketing and production are done in Flower Mound, Texas. Research and development are performed in Germantown, Maryland.